|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online June 8, 2001 as doi:10.1096/fj.00-0685fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-casozepine, a tryptic peptide from bovine
s1-casein with benzodiazepine-like activity1

,3
* Laboratoire des Biosciences de lAliment UA 885 INRA, Faculté des Sciences, Université Henri Poincaré-Nancy 1, Vandoeuvre-lès-Nancy, France;
Departments of Cell Biology, Pharmacology and Neuroscience, Georgetown University Medical Center, Washington, D.C. 20007, USA;
¶ Laboratoire de Chimie Physique Macromoléculaire UMR CNRS, ENSIC, Nancy, France;
|| Ingredia, Arras, France; and
** Laboratoire des Aspects Fonctionnels et du Développement des Comportements URA 1293 CNRS, Faculté des Sciences, Université Henri Poincaré-Nancy 1, Vandoeuvre-lès-Nancy, France
2Correspondence: LBSA, Faculté des Sciences, Université Henri Poincaré-Nancy 1, B.P. 239, 54506 Vandoeuvre-lès-Nancy, France. E-mail: Laurent.Miclo{at}scbiol.uhp-nancy.fr
SPECIFIC AIMS
According to folk wisdom, milk intake improves sleeping or has a calming
role, a belief supported by some scientific studies. As caseins contain
peptides with physiological roles, we hypothesized that one of their
peptides can carry this anxiolytic activity. In this study,
s1-casein tryptic hydrolysate
(
s1-CnTH) was tested in vitro on
benzodiazepine (BDZ) receptors and checked in vivo for its
anticonvulsant and anxiolytic effects in the rat.
PRINCIPAL FINDINGS
1.
s1-CnTH inhibits pentylenetetrazole (PTZ)
-induced seizures in Wistar rat
Bovine
s1-CnTH was injected
intraperitoneally (i.p.) in a Wistar rat 30 min before an i.p.
injection of 60 mg/kg of PTZ to evaluate anticonvulsant activity.
Crisis severity parameters, crisis latency, and clonus duration were
determined after 45 min observation of behavior. The i.p. injection of
1 mg/kg of
s1-CnTH reduced crisis severity
(P<0.02). Other parameters were not significantly different
from the control. The i.p. injection of 3 mg/kg of
s1-CnTH increased crisis latency
(P<0.005), decreased crisis severity (P<0.002),
and decreased clonus duration (P<0.005) of PTZ-induced
seizures. The anticonvulsant action of the
s1-CnTH was underestimated because of a
sensitization of animals to PTZ during successive experiments.
2.
s1-CnTH displays an anxiolytic activity in the
elevated plus maze paradigm
Elevated plus maze test was used to evaluate the anxiolytic effect
of the
s1-CnTH. Diazepam (1 mg/kg) and
s1-CnTH (3 mg/kg) enhanced
(P<0.02) the percentage of entries in the open arms whereas
general activity, represented by entries in closed arms, was not
modified (Fig. 1
).
|
3.
s1-CnTH displays an anxiolytic activity in the
conditioned defensive burying (CDB) experiment
When a rat is shocked once through an electrical probe mounted on
a wall of a test cage, it returns to the probe and buries it with
bedding material from the floor of the cage. This CDB response is
reduced by anxiolytic drugs. Some behavioral sequences such as
exploratory approaches to the probe and escape movements from the probe
are needed to differentiate agonists from partial inverse agonists.
Similar to diazepam, the
s1-CnTH,
administrated at 3 mg/kg i.p., decreased the duration of probe burying
(P<0.005) (Fig. 2
). The ratio of the retreats to the approaches decreased in rats treated
with
s1-CnTH or diazepam. The CDB paradigm
indicates that the
s1-CnTH exerts an
anxiolytic activity over rats.
|
4. A peptide (
-casozepine) of the
s1-CnTH binds
on the BDZ site of the GABAA receptor
Affinity for the BDZ site of the GABAA
receptor from bovine cerebral cortex membranes was measured
in competition with
[methyl-3H]-flunitrazepam.
s1-CnTH competed with the radioligand for
binding on the BDZ site of the GABAA receptor
with an IC50 of 72 µM and a Hill number of 0.8.
All peptides of the
s1-CnTH were purified and
tested in competition with the radioligand. Only one peptide exhibited
affinity for the BDZ site of the GABAA receptor.
The sequence and mass of this peptide corresponded to those of the
s1-casein-(f91100); it has consequently been
named
-casozepine. This purified peptide competed against
[methyl-3H]-flunitrazepam in binding
assays withan IC50 of 88 µM and a Hill
number of 0.8 compared to an IC50 value for
diazepam of 8.2 nM determined under the same conditions. The
synthetic
-casozepine also displaced the radioligand from the BDZ
site of GABAA receptor, but was fourfold less
potent than the milk-purified peptide. These findings indicate that the
s1-casein-(f91100) carries the activity of
the
s1-CnTH.
5. The
-casozepine exhibits an anxiolytic activity in vivo
-Casozepine was tested in the CDB paradigm. This peptide
administrated i.p. at 0.4 mg/kg (0.32 µmol/kg) decreased the duration
of probe burying compared to saline (P<0.005) (Fig. 2)
.
Other behavioral parameters show the same modifications as observed
with the
s1-CnTH. Effects of
-casozepine
were comparable to those induced by diazepam injected i.p. at 1 mg/kg
(3.5 µmol/kg). The
-casozepine seems to be
10-fold more active
than diazepam in vivo despite the lower binding affinity of the tryptic
fragment for the BDZ site of the GABAA receptor
in vitro.
6. Effects of
-casozepine are not mediated by the
peripheral-type BDZ receptor (PBR)
PBR are a second class of BDZ binding receptor with predominant
mitochondrial localization. The possibility that the peptide would act
via the PBR was examined. The binding ability of
-casozepine to PBR
was tested on MA-10 mouse Leydig cell mitochondrial preparation in
competition experiments against two specific ligands of PBR. No
displacement of these ligands was observed, indicating that
-casozepine did not bind to PBR. Moreover,
-casozepine did not
significantly affect progesterone production by MA-10 mouse Leydig
cells. These results exclude the possibility for PBR to be a target of
the
-casozepine and suggest that this peptide is specific for the
BDZ site of the GABAA receptor.
CONCLUSIONS
Cows milk has long been considered a tranquilizing beverage with
sleep-inducing capacity, but the molecular bases of this potential
action are not known. Cow or human breast milks contain BDZ-like
molecules, even in the absence of BDZ administration. However, the
concentrations of these milk BDZ-like compounds are very lowonly a
few micrograms per liter. This study demonstrated that a peptide
stemming from the hydrolysis of
s1-casein by
trypsin, the only protease of the gastrointestinal tract that is in
equal concentration and activity in the newborn and adult, exhibited a
BDZ-like activity. In two behavioral tests, elevated plus maze test and
CDB paradigm,
s1-CnTH exhibited the
characteristic profile of full BDZ agonists such as diazepam. Moreover,
s1-CnTH suppressed the inhibitory effect of
PTZ on the GABAergic system. These results were consistent with the
binding of one of the peptides of the
s1-CnTH
to the BDZ site of the GABAA receptor. This
peptide, named
-casozepine, corresponds to the
s1-casein-(f91100) (Fig. 3
). Despite a lower in vitro affinity than diazepam for the BDZ site of
the GABAA receptor,
-casozepine might be
10-fold more active in vivo than the BDZ. Although
-casozepine
displays the characteristic anxiolytic and anticonvulsant effects of
BDZ, it does not trigger any side effects. The lack of affinity of
-casozepine for PBR and its small effect on steroidogenesis exclude
this way of action. Whereas the present results clearly show that
-casozepine is acting via the GABAA receptor,
the difference of efficiency between in vivo and in vitro experiments
remains unclear. A physiological relevance of modulation of the
GABAergic system through the BDZ site of the
GABAA receptor implies the presence of an
endogenous ligand.
|
Until now, attempts to identify an endogenous agonist ligand of the BDZ
site of the GABAA receptor have failed. A 86
residue endogenous peptide called diazepam binding inhibitor (DBI)
inhibits competitively the binding of BDZ to the
GABAA receptor with an IC50
of
4 µM. DBI is the precursor of two peptides, ODN
[DBI-(f3350)] and TTN [DBI-(f1750)], that carry the BDZ
receptor binding activity. However, DBI and its fragments have effects
opposite to those of BDZ-like agonists. In behavioral paradigms, DBI
and its fragments are anxiogenic, which means they are anxiety factors.
Moreover, DBI displays epileptogenic activity. A comparison of the
carboxyl-terminal region of DBI (residues 73 to 82) from different
species and bovine
-casozepine shows a great homology of sequence
and structure. This region of DBI does not relate to the ODN or the TTN
peptides. The region 7382 of DBI belongs to the fragment 6683,
which is predicted to form a helix. The fragment 91100 of the bovine
s1-casein is predicted to insert in a helical
region, whereas only 15% of the
s1-casein
residues belong to
-helix structures. We have shown that the bovine
DBI-(f7382) injected i.p. at 1 mg/kg in Wistar rats displayed an
anxiolytic activity in the plus maze experiment. At this time, we
cannot conclude whether the DBI-(f7382) can be generated by in vivo
hydrolysis of DBI.
Casein from bovine milk contains a latent peptide with BDZ-like
properties that may be released upon proteolytic hydrolysis, which
could explain the calming properties attributed to this beverage. This
peptide, which displays strong in vivo anxiolytic activity in the rat,
is homologous to a peptide of the carboxyl-terminal region of DBI. Our
results also raised the possibility that the carboxyl-terminal part of
DBI could act as an agonist of physiological importance in regulating
anxiety. Moreover, this suggests that bovine
-casozepine, or the
equivalent in other mammal species, may act as an exogenous ligand for
the BDZ site of the GABAA receptor in newborn
brain, thus regulating anxiety in the newborn.
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.00-0685fje ; to cite this article, use FASEB J. (June 8, 2001) 10.1096/fj.00-0685fje ![]()
3 Present address: Endocrinologie Moléculaire de la Reproduction UMR 6026 CNRS Interactions Cellulaires et Moléculaires, Université de Rennes 1, Campus de Beaulieu, 35042 Rennes Cedex, France. ![]()
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |